{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:27:05Z","timestamp":1777984025625,"version":"3.51.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Persistent high-risk human papillomavirus (hrHPV) infections predispose to long follow-ups in cervical cancer screening. We aimed to examine the role of different persistent hrHPV genotypes in causing cervical disease in long-term follow-up. This study included 76 482 women who participated in Finland\u2019s national cervical cancer screening program in the Tampere region between 2012 and 2023. Partial HPV genotyping identified HPV16, HPV18, and 12 other hrHPV-types. Participants were grouped by age: less than 40, 40\u201350, and more than 50 years. Women with persistent HPV infections and baseline cytology of atypical squamous cells of undetermined significance (ASC-US) or milder were followed to assess their risk of developing high-grade squamous intraepithelial lesion or worse (HSIL+). Out of 4646 baseline HPV-positive women with ASC-US or lower cytology, 38.0% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2005=\u20051765) had a type-specific persistent infection. The mean interval between consecutive positive samples was 15.8 months (range: 0.5\u20134 years). HPV16 demonstrated the highest persistence rate (39.8%). HPV16 coinfection was associated with the highest risk of HSIL+ (hazard ratio: 2.34, 95% confidence interval: 1.38\u20133.97) and significantly slower viral clearance (HR: 0.35, 95% CI: 0.17\u20130.70) compared with other hrHPV genotypes. The youngest age group (&lt;40 years) was more prone to developing HSIL+ (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001) but cleared persistent infections significantly faster (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0028) than older cohorts. Our findings highlight that the oncogenic potential and persistence potential of the specific partial HPV genotypes vary across age groups. These differences should be considered when designing follow-up stratification strategies for cervical cancer screening programs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000001020","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:00:44Z","timestamp":1777982444000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Persistent human papillomavirus following mild cytology at screening: implications for age-stratified follow-up and triage"],"prefix":"10.1097","author":[{"given":"Eero","family":"Numminen","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Technology, Tampere University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarno","family":"Leino","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Technology, Tampere University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saara","family":"Kares","sequence":"additional","affiliation":[{"name":"Fimlab Laboratories, Department of Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Kotaniemi-Talonen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Technology, Tampere University"},{"name":"Department of Obstetrics and Gynaecology, Tampere University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Kholov\u00e1","sequence":"additional","affiliation":[{"name":"Fimlab Laboratories, Department of Pathology"},{"name":"Department of Pathology, Faculty of Medicine and Health Technology, Tampere University, Tampere"},{"name":"Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland"},{"name":"Department of Clinical Pathology, Diagnostic Imaging Center, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Louvanto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Technology, Tampere University"},{"name":"Department of Obstetrics and Gynaecology, Tampere University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"R1-20260505","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","article-title":"Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.","volume":"337","author":"Arbyn","year":"2008","journal-title":"BMJ"},{"key":"R2-20260505","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41416-020-0787-9","article-title":"Triage of HPV-positive women in Norway using cytology, HPV16\/18 genotyping and HPV persistence.","volume":"122","author":"Arbyn","year":"2020","journal-title":"Br J Cancer"},{"key":"R3-20260505","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cmi.2021.04.031","article-title":"2020 List of human papillomavirus assays suitable for primary cervical cancer screening.","volume":"27","author":"Arbyn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R4-20260505","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ygyno.2019.05.024","article-title":"Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.","volume":"154","author":"Aro","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R5-20260505","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/03008916251395597","article-title":"Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: analysis of 5-year outcomes.","volume":"112","author":"Bogani","year":"2026","journal-title":"Tumori"},{"key":"R6-20260505","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R7-20260505","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12985-019-1252-3","article-title":"HPV16 persistent infection and recurrent disease after LEEP.","volume":"16","author":"Bruno","year":"2019","journal-title":"Virol J"},{"key":"R8-20260505","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12885-020-06946-7","article-title":"Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.","volume":"20","author":"Bruno","year":"2020","journal-title":"BMC Cancer"},{"key":"R9-20260505","first-page":"100729","article-title":"HPV testing for cervical cancer screening: should reflex cytology be performed after a positive test for HPV 16 and 18?","volume":"36","author":"Caeiro","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"R10-20260505","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1055-9965.EPI-10-1267","article-title":"Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.","volume":"20","author":"Castle","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R12-20260505","doi-asserted-by":"crossref","first-page":"100293","DOI":"10.1016\/j.eclinm.2020.100293","article-title":"A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs.","volume":"22","author":"Demarco","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R13-20260505","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2014.03.552","article-title":"Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65.","volume":"133","author":"Dickson","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R14-20260505","first-page":"548","article-title":"Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia.","volume":"34","author":"Du","year":"2013","journal-title":"Eur J Gynaecol Oncol"},{"key":"R15-20260505","doi-asserted-by":"crossref","first-page":"264.e1","DOI":"10.1016\/j.ajog.2016.10.042","article-title":"Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.","volume":"216","author":"Elfgren","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20260505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23280","article-title":"HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.","volume":"23","author":"Gilham","year":"2019","journal-title":"Health Technol Assess"},{"key":"R18-20260505","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1002\/ijc.24794","article-title":"Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia.","volume":"126","author":"Kim","year":"2010","journal-title":"Int J Cancer"},{"key":"R19-20260505","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/v13071342","article-title":"Multiple human papilloma virus (HPV) infections are associated with HSIL and persistent HPV infection status in Korean patients.","volume":"13","author":"Kim","year":"2021","journal-title":"Viruses"},{"key":"R20-20260505","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.","volume":"102","author":"Kj\u00e6r","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R21-20260505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am J Epidemiol"},{"key":"R22-20260505","doi-asserted-by":"crossref","first-page":"i3633","DOI":"10.1136\/bmj.i3633","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis.","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"R23-20260505","first-page":"CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20260505","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2019.05.026","article-title":"Association of age and viral factors with high-risk HPV persistence: a retrospective follow-up study.","volume":"154","author":"Li","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R25-20260505","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/aogs.14915","article-title":"Clinical performance of human papillomavirus based cervical cancer screening algorithm: the result of a large Danish implementation study.","volume":"103","author":"Lindquist","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R26-20260505","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncy.21521","article-title":"The Pap test and Bethesda 2014.","volume":"123","author":"Nayar","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"R27-20260505","doi-asserted-by":"crossref","first-page":"927131","DOI":"10.3389\/fcimb.2022.927131","article-title":"Role of immunity and vaginal microbiome in clearance and persistence of human papillomavirus infection.","volume":"12","author":"Ntuli","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R28-20260505","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"R29-20260505","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R30-20260505","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jnci\/djq001","article-title":"Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection.","volume":"102","author":"Rodr\u00edguez","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R31-20260505","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/ijc.31883","article-title":"Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.","volume":"144","author":"Sand","year":"2019","journal-title":"Int J Cancer"},{"key":"R32-20260505","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","article-title":"Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.","volume":"286","author":"Schlecht","year":"2001","journal-title":"JAMA"},{"key":"R33-20260505","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: concepts and clinical implications.","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol"},{"key":"R34-20260505","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2013.11.002","article-title":"The human papillomavirus family and its role in carcinogenesis.","volume":"26","author":"Tommasino","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"R35-20260505","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/aogs.13013","article-title":"Human papillomavirus test with cytology triage in organized screening for cervical cancer.","volume":"95","author":"Veijalainen","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R36-20260505","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature.","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"key":"R37-20260505","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2019.10.003","article-title":"Co-infections of HPV16\/18 with other high-risk HPV types and the risk of cervical carcinogenesis: a large population-based study.","volume":"155","author":"Wu","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000001020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:00:48Z","timestamp":1777982448000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000001020","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"2025-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}